Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Structure Therapeutics Inc. Director's Dealing 2024

Feb 15, 2024

31940_dirs_2024-02-15_3387c21a-aeab-42ed-8dee-d31c13d48673.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Structure Therapeutics Inc. (GPCR)
CIK: 0001888886
Period of Report: 2024-02-13

Reporting Person: FMR LLC (10% Owner, See Remark 1)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2024-02-13 American Depositary Shares $ S 525 Disposed Ordinary Shares (1575) Indirect

Holdings (Non-Derivative)

Security Shares Ownership
Ordinary Shares 45120 Indirect
Ordinary Shares 530814 Indirect

Holdings (Derivative)

Security Exercise Price Expiration Underlying Shares Ownership
American Depositary Shares $ Ordinary Shares (123) 41 Indirect
American Depositary Shares $ Ordinary Shares (8199) 2733 Indirect
American Depositary Shares $ Ordinary Shares (96507) 32169 Indirect

Footnotes

F1: Reported securities are American Depositary Shares, each of which represents three Ordinary Shares of the Issuer. Any one American Depositary Share may be converted into three Ordinary Shares, and any three Ordinary Shares into one American Depositary Share, at any time at the election of the holder upon notice.